Immediate Impact
27 standout
Citing Papers
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
2024 Standout
2023 FDA TIDES (Peptides and Oligonucleotides) Harvest
2024 Standout
Works of Daniel Lashley being referenced
Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7
2010
Congenital Myasthenic Syndromes and the Formation of the Neuromuscular Junction
2008
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Daniel Lashley | 235 | 122 | 33 | 92 | 13 | 321 | |
| Amina Chaouch | 184 | 143 | 33 | 113 | 13 | 307 | |
| Richard W. Tim | 185 | 137 | 82 | 32 | 10 | 361 | |
| M. Janka | 107 | 186 | 48 | 37 | 14 | 333 | |
| A. N. Bender | 287 | 67 | 44 | 27 | 9 | 370 | |
| Josiah Chai | 141 | 66 | 48 | 21 | 17 | 294 | |
| Annabel K. Wang | 101 | 120 | 27 | 48 | 10 | 267 | |
| Marina Dusl | 215 | 135 | 28 | 125 | 10 | 308 | |
| Stayko Sarafov | 65 | 202 | 29 | 36 | 20 | 279 | |
| Ágnes Herczegfalvi | 64 | 164 | 26 | 49 | 21 | 263 | |
| Crystal Davis | 109 | 184 | 42 | 14 | 10 | 350 |
All Works
Login with ORCID to disown or claim papers
Loading papers...